ArticleOxford medical case reports2026
Cholestatic liver disease in an adolescent: don't forget progressive familial intrahepatic Cholestasis-8.
Article in Oxford medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Progressive familial intrahepatic cholestasis (PFIC) is an inherited disorder affecting bile acid secretion, with a heterogenous clinical presentation including pruritus, jaundice, growth failure, hepatosplenomegaly, and cirrhosis. Most patients present in infancy or early childhood, leading to progressive liver disease and potentially liver failure, often requiring liver transplantation. We present a 14-year-old girl with incidentally detected cholestasis. She had no previous jaundice, abdominal pain, clay stools, or pruritus. Hypergammaglobulinemia and a positive antinuclear antibody titer was found on testing. Liver biopsy revealed bile duct destruction and interface hepatitis, which initially led us to suspect an autoimmune hepatitis-primary sclerosing cholangitis overlap. However, her poor response to steroids over 6 weeks led us to perform whole exome sequencing, which found a homozygous mutations of KIF12(-) gene at intron 9, suggestive of PFIC-8. This case highlights the importance of genetic testing in atypical cholestasis, particularly in adolescents who do not respond to empirical therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.